文献速递白血病

急性髓系白血病通过外泌体分泌将骨髓微环境改造为白血病许可性微环境

Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
PubMed 文献 · Leukemia · 2017-08-17

该研究探讨急性髓系白血病(AML)细胞如何通过外泌体分泌重塑骨髓微环境。小鼠体内实验显示,AML细胞或AML来源外泌体增加间充质基质祖细胞、阻断骨系发育与骨形成,预处理AML外泌体可加速白血病生长;靶向Rab27a阻断外泌体分泌则显著延缓白血病发展。AML外泌体诱导基质细胞表达DKK1,DKK1抑制剂可延缓白血病进展并延长生存;外泌体还下调CXCL12、KITL、IGF1等造血干细胞支持因子,削弱正常造血支持能力。

要点

  • AML细胞或AML来源外泌体在小鼠体内增加间充质基质祖细胞并阻断骨系发育和骨形成。
  • AML外泌体预处理可加速小鼠白血病生长,靶向Rab27a阻断外泌体分泌则显著延缓白血病发展。
  • DKK1抑制剂可延缓AML进展并延长AML移植小鼠生存。

核心结论

  • AML细胞通过外泌体分泌创建自我强化的白血病微环境,促进白血病细胞增殖与存活并抑制正常造血。

研究设计与样本

  • 研究采用AML细胞或AML来源外泌体移植的小鼠体内实验,并靶向Rab27a阻断AML细胞外泌体分泌。

主要发现

  • 移植的AML细胞或AML来源外泌体在小鼠体内增加间充质基质祖细胞并阻断骨系发育和骨形成。
  • AML来源外泌体预处理可加速小鼠AML生长;靶向Rab27a阻断外泌体分泌显著延缓白血病发展。
  • AML来源外泌体诱导骨髓基质细胞表达DKK1,导致成骨细胞丢失;DKK1抑制剂延缓AML进展并延长AML移植小鼠生存。
  • AML来源外泌体广泛下调骨髓基质细胞中CXCL12、KITL和IGF1等造血干细胞支持因子,并降低其支持正常造血的能力。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Little is known about how leukemia cells alter the bone marrow (BM) niche to facilitate their own growth and evade chemotherapy. Here, we provide evidence that acute myeloid leukemia (AML) blasts remodel the BM niche into a leukemia growth-permissive and normal hematopoiesis-suppressive microenvironment through exosome secretion. Either engrafted AML cells or AML-derived exosomes increased mesenchymal stromal progenitors and blocked osteolineage development and bone formation in vivo. Preconditioning with AML-derived exosomes 'primed' the animals for accelerated AML growth. Conversely, disruption of exosome secretion in AML cells through targeting Rab27a, an important regulator involved in exosome release, significantly delayed leukemia development. In BM stromal cells, AML-derived exosomes induced the expression of DKK1, a suppressor of normal hematopoiesis and osteogenesis, thereby contributing to osteoblast loss. Conversely, treatment with a DKK1 inhibitor delayed AML progression and prolonged survival in AML-engrafted mice. In addition, AML-derived exosomes induced a broad downregulation of hematopoietic stem cell-supporting factors (for example, CXCL12, KITL and IGF1) in BM stromal cells and reduced their ability to support normal hematopoiesis. Altogether, this study uncovers novel features of AML pathogenesis and unveils how AML cells create a self-strengthening leukemic niche that promotes leukemic cell proliferation and survival, while suppressing normal hematopoiesis through exosome secretion.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Kumar B, Garcia M, Weng L, et al. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion. Leukemia. 2017. PMID: 28816238. doi:10.1038/leu.2017.259

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。